|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Ben SessaPublisher: Muswell Hill Press Imprint: Muswell Hill Press Edition: Second Edition ISBN: 9781908995254ISBN 10: 1908995254 Pages: 402 Publication Date: 01 April 2017 Audience: General/trade , General Format: Paperback Publisher's Status: Active Availability: Not yet available ![]() This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsForeword to 2017 Edition by Robin Carhart-Harris Endorsements by Dennis McKenna, Andy Roberts, David Nutt, Rick Doblin, Amanda Feilding, Ralph Metzner and Michael Mithoefer Introduction 1. Personal Reflection 2. The Experience and the Drugs 3. Early Pioneers of the First and Second Psychedelic Eras 4. The Prehistory and Ancient History of Hallucinogens 5. Hippie Heydays, Ravers and the Birth of Ecstasy 6. Psychedelic Creativity 7. Modern Uses of Natural Plant and Fungi Psychedelics 8. The Psychedelic Renaissance Part One: Movers and Shakers 9. The Psychedelic Renaissance Part Two: Contemporary Studies 10. Psychedelics Caught in the Crossfire of the War on Drugs Conclusion Acknowledgments Notes Bibliography and Further Reading IndexReviews...remains the best introductory book on the topic ... Highly recommended. - CHOICE Ben Sessa takes the reader on a journey through the fascinating history of psychedelic plants and chemicals, examining their role in human culture from prehistory to modern times. Based on a thorough review of scientific evidence, he makes a clarion call for a reevaluation of their clinical potential with appropriate setting in scientific research, psychiatry, psychotherapy, and personal growth. First published in 2012, Psychedelic Renaissance has been extensively revised and expanded to incorporate the extraordinary developments in research into psychedelics over the intervening years. Author InformationBen Sessa is a medical doctor and consultant psychiatrist. He is senior research fellow at the University of Bristol, Cardiff University, and Imperial College London, where he is currently conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence. Dr. Sessa is outspoken on lobbying for change in the current system by which drugs are classified, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is a cofounder and director of the UK's Breaking Convention conference. Tab Content 6Author Website:Countries AvailableAll regions |